Tags 
STAT3
 |
Medicilon Assists Yuyao Biotech's STAT3 dual phosp..A Story by MedicilonShanghai Medicilon Inc. (Medicilon), as a partner of Yuyao Biotech, provided YY201 with pharmaceutical research services (including raw materials and .. |
 |
STAT3-targeted Drugs R&D ServiceA Story by MedicilonSTAT3, a member of the STAT family, is a latent transcription factor that is activated in response to various cytokines, growth factors, and oncogene .. |
 |
Medicilon Assists Yuyao Biotech's STAT3 dual phosp..A Story by MedicilonRecently, YY201, a STAT3 dual phosphorylation site inhibitor independently developed by Yuyao Biotech, was approved by the US FDA and agreed to conduc.. |
 |
Medicilon Interview with Dr. Wenbo Zhou | Focusing..A Story by MedicilonThe interaction between drugs and targets is the basis of drug design. Scientists have discovered more than 4,000 disease-related targets, but 85% of.. |
Share This